Skull bone infarctive crisis and deep vein thrombosis in homozygous sickle cell disease- case report and review of the literature

References

• Keeley K, Buchanan GR. Acute infarction of long bones in children with sickle cell anemia. J Pediatr 1982;101:170.
   PubMed Web of Science ®Google Scholar
• Stevens MCG, Padwick M, Serjeant GR. Observations on the natural history of dactylitis in homozygous sickle cell disease. Clin Pediatr 1981;20:311.
   Google Scholar
• Bousser MG, Welch KM. Relation between migraine and stroke. Lancet Neurol 2005;4(9):533–542.
   PubMed Web of Science ®Google Scholar
• Tentschert S, Wimmer R, Greisenegger S, Lang W, Lalouschek W. Headache at stroke onset in 2196 patients with ischaemic stroke or transient ischaemic attack. Stroke 2005;36(2): el —e3 (Epub 2004 Dec 16).
   Web of Science ®Google Scholar
• Garty I, Koren A, Katzumi E. Uncommon sites of bone infarction in a sickle cell anaemia patient. Eur J Nucl Med 1983;8(8):367–368.
   Google Scholar
• Resar LM, Oliva MM, Casella JF. Skull infarction and epidural hematomas in a patient with sickle cell anemia. J Pediatr Haematol Oncol 1996;18(4):413–415.
   Google Scholar
• Royal JE, Harris VJ, Sansi PK. Facial bone infarcts in sickle cell syndromes. Radiology 1998;169(2):529–531.
   Google Scholar
• Naran AD, Fontana L. Sickle cell disease with orbital infarction and epidural hematoma. Pediatr Radiol 2001;31 (4):257–259.
   PubMed Web of Science ®Google Scholar
• Ganesh A, William RR, Mitra S, Yanamadala S, Hussein SS, Al-Kindi S, Zakariah M, Al-Lamki Z, Knox-Macaulay H. Orbital involvement in sickle cell disease: A report of five cases and review of the literature. Eye 2001;15(Pt 6):774–780.
   Google Scholar
• Seibert RW, Seibert JJ, Frazier EA. Infarction of the orbit and paranasal sinuses in sickle cell disease. South Med J 1987;80(12):1569–1571.
   Google Scholar
• Katz RS, Abrams G. Orbital subperiosteal hematoma (epidural haematoma of the orbit). J Clin Neuroopthalmol 1981;1(1):45–52.
   PubMedGoogle Scholar
• Dixit A, Chatterjee TC, Papneja M, Mishra P, Mahapatra M, Pati HP, Saxena R, Choudhry VP. Sickle beta-thalassaemia presenting as orbital compression syndrome. Ann Hematol 2004;83(8):536–540.
   PubMed Web of Science ®Google Scholar
• Curran EL, Fleming JC, Rice K, Wang WC. Orbital compression syndrome in sickle cell disease. Opthalmology 1997;104(10):1610–1615.
   PubMed Web of Science ®Google Scholar
• Mallouh AA, Young M, Hamdan J, Salamah MM. Proptosis, skull infarction, and retro-orbital and epidural hematomas in a child with sickle cell disease. Clin Pediatr (Phila) 1987; 26(10):536–538.
   PubMed Web of Science ®Google Scholar
• Sidman JD, Brownlee RE, Smith WC, Fry TL. Orbital complications of sickle cell disease. Int J Pediatr Otorhinolar-yngol 1990;19(2):181–184.
   PubMed Web of Science ®Google Scholar
• Gorgulu A, Cobanoglu S, Armagan S, Karabagli A, Tevruz M. Bilateral epidural hematoma. Neurosurg Rev 2000;23(1): 30–33.
   PubMed Web of Science ®Google Scholar
• Sato M, Mori K. [Postoperative epidural hematoma-five cases of epidural hematomas developed after supratentorial craniotomy on the contra-lateral side (author’s transl)]. No Sheinkei Geka 1981;9(11):1297–1302. [Article in Japanese].
   PubMedGoogle Scholar
• Rebsamen SL, Bilaneuk LT, Granet D, Foster J, Low J, Heyman S, Katowitz J. Orbital wall infarction in sickle cell disease: MR evaluation. AJNR Am J Neuroradiol 1993; 14(3):777–779.
   PubMedGoogle Scholar
• Naidu MR, Reddy DR, Sastry KV, Reddy PK. Unilateral proptosis secondary to diffuse condensing osteomyelitis. Clin Neurol Neurosurg 1987;89(4):265–267.
   PubMed Web of Science ®Google Scholar
• Koren A, Zalman L, Levin C, Abu Hana M, Mader R, Shalev S. Venous thromboembolism, factor V Leiden, and methyle-netetrahydrofolate reductase in a sickle cell anaemia patient. J Pediatr Hematol Oncol 1999;15(5):469–472.
   Google Scholar
• Ng PC, Ashari L. Portal vein thrombosis following laparo-scopic surgery in a patient with sickle cell disease. Surg Endosc 2003;17(5):831.
   PubMed Web of Science ®Google Scholar
• Bakhshi S, Sarnaik SA, Bloom DA, Warner I. Inferior vena caval thrombosis with sickle cell disease and heterozygous protein’s deficiency. J Pediatr Hematol Oncol 2002;24(6): 509–510.
   PubMed Web of Science ®Google Scholar
• Ivil KD, Mannion SJ. Haemoglobin SC disease presenting with a compartment syndrome secondary to deep vein thrombosis. Int J Clin Pract 2000;54(10):679–680.
   PubMed Web of Science ®Google Scholar
• Arnold KB, Char G, Serjeant GR. Portal vein thrombosis in a child with homozygous sickle-cell disease. West Indian Med J 1993;42(1):27–28.
   Google Scholar
• Humphries JE, Wheby MS. Case report: Sickle cell trait and recurrent deep vein thrombosis. Am J Med Sci 1992;303(2): 112–114.
   PubMed Web of Science ®Google Scholar
• Hasan S, Elbedawi M, Castro O, Gladwin M, Palestine A. Central retinal vein occlusion in sickle cell disease. South Med J 2004;97(2):202–204.
   Google Scholar
• Stuart MJ, Setty BN. Hemostatic alterations in sickle cell disease: Relationships to disease pathophysiology. Pediatr Path Mol Med 2001;20:27–46.
   PubMed Web of Science ®Google Scholar
• Tomer A, Harker LA, Kasey S, Eckman JR. Thrombogenesis in sickle cell disease. J Lab Clin Med 2001;137:398–407.
   PubMed Web of Science ®Google Scholar
• Westerman MP, Green D, Gilman-Sachs A, et al. Antipho-spholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med 1999;134: 352–362.
   Google Scholar
• Setty BN, Ran AK, Stuart MJ. Thrombophilia in sickle cell disease: The red cell connection. Blood 2001;98:3228–3233.
   Google Scholar
• Solovey A, Gui L, Key NS, Hebbel RP. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest 1998;101:l899–1904.
   PubMed Web of Science ®Google Scholar
• Wright JG, Malia R, Cooper P, et al. Protein C and protein Sin homozygous sickle cell disease: Does hepatic dysfunction contribute to low levels? Br J Haematol 1997;98:627–631.
   PubMed Web of Science ®Google Scholar
• Francis RB, Johnson CS. Vascular occlusion in sickle cell disease: Current concepts and unanswered questions. Blood 1991;77:1405.
   PubMed Web of Science ®Google Scholar
• Stockman JA, Nigro MA, Mishkin MM, Oski FA. Occlusion of large cerebral vessels in sickle-cell anaemia. N Engl J Med 1972;287:846.
   PubMed Web of Science ®Google Scholar
• Rothman SM, Fulling KH, Nelson JS. Sickle cell anemia and central nervous system infarction: A neuropathological study. Ann Neurol 1986;20: 684.
   Google Scholar
• Zimmerman SA, Ware RE. Inherited mutations contributing to thrombotic complications in patients with sickle cell disease. Am J Hematol 1998;59:267–272.
   PubMed Web of Science ®Google Scholar
• DeCastro L, Rinder HM, Howe JG, Smith BR. Thrombo-philic genotypes do not adversely affect the course of sickle cell disease (SCD). Blood 1998;92:161a.
   Web of Science ®Google Scholar
• Kutlar F, Tural C, Park D, et al. MTHFR (5, 10-methylenetetrahydrofolate reductase) 677 C → T mutation as a candidate risk factor for avascular necrosis in patients with sickle cell disease. Blood 1998;92:695a.
   PubMed Web of Science ®Google Scholar
• Liesner R, Mackie I, Cookson J, et al. Prothrombotic changes in children with sickle cell disease: Relationships to cerebrovascular disease and transfusion. Br J Haematol 1998;103:1037–1044.
   PubMed Web of Science ®Google Scholar
• Nsiri B, Ghazouani E, Gritli N, et al. Antiphospholipid antibodies: Lupus anticoagulants anticardiolipin and antipho-spholipid isotypes in patients with sickle cell disease. Hematol Cell Ther 1998;40:107–112.
   PubMedGoogle Scholar
• Anyaegbu CC, Okpala IE, Akren’Ova YA, Salimonu LS. Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA). Eur J Haem 1998;60:267–268.
   Google Scholar
• Platt OS, Brambilla DJ, Rosse WE, et al. Mortality in sickle cell disease-life expectancy and risk factors for early death. N Eng J Med 1994;330:1639–1643.
   PubMed Web of Science ®Google Scholar
• Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebro-vascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91:288–294.
   Google Scholar
• Powers DR. Management of cerebral vasculopathy in children with sickle cell anaemia. Br J Haematol 2000;108:666–678.
   PubMed Web of Science ®Google Scholar
• Kinney TR, Sleeper LA, Wang WC, et al. Silent cerebral infarcts in sickle cell anaemia: A risk factor analysis. Paediatrics 1999;103:640–645.
   PubMed Web of Science ®Google Scholar
• Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome of sickle cell disease: Incidence and risk factors. The co-operative study of sickle cell disease. Blood 1994;84: 643–649.
   Google Scholar
• Abboud M, Laver J, Blau CA. Granulocytosis causing sickle cell crisis. Lancet 1998;351:959.
   Google Scholar
• Alder BK, Salzman DE, carabasi MH, et al. Fatal sickle cell crisis after granulocyte colony-stimulating factor adminis-tration. Blood 2001;97:3313–3314.
   PubMed Web of Science ®Google Scholar
• Chrache S. The mechanism of action of hydroxyurea in the management of sickle cell anaemia in adults. Semin Hematol 1997;34\(suppl 3):15–21.
   PubMed Web of Science ®Google Scholar
• Stevens MCG, Hayes RJ, Vaidya S, Serjeant GR. Fetal hemoglobin and clinical severity of homozygous sickle disease. J Pediatr 1981;98:37–41.
   PubMed Web of Science ®Google Scholar
• Bailey K, Morris J, Serjeant GR. Fetal hemoglobin and early manifestation of homozygous sickle cell disease. Arch Dis Child 1992;67:517–520.
   PubMedGoogle Scholar
• Koshy M, Entsouh R, Koranda A, et al. Leg ulcers in patients with sickle cell disease. Blood 1989;74:1403–1408.
   PubMed Web of Science ®Google Scholar
• Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991; 325:11–16.
   PubMed Web of Science ®Google Scholar
• Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: Incidence and risk factors. Blood 1994;84:643–649.
   PubMed Web of Science ®Google Scholar
• Al-Awamy B, Wilson WA, Pearson HA. Splenic function in sickle cell disease in the Eastern Province of Saudi Arabia. J Pediatr 1984;104:714–717.
   Google Scholar
• Mallouh AA, Burke GM, Salamah M, Ahmad MS. Splenic function in Saudi children with sickle cell disease. Ann Trop Pediatr 1984;4:87–91.
   PubMedGoogle Scholar
• Stevens MCG, Hayes RJ, Vaidya S, Serjeant GR. Fetal haemoglobin and clinical severity of homozygous sickle cell disease in early childhood. J Pediatr 1981;98:37–41.
   PubMed Web of Science ®Google Scholar
• Gelpi AP. Benign sickle cell disease in Saudi Arabia: Survival estimate and population dynamics. Clin Genet 1979;15: 307–310.
   PubMed Web of Science ®Google Scholar
• Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1991;325:11–16.
   PubMed Web of Science ®Google Scholar